Surgeon-Specific Learning Curve for Transoral Robotic Surgery

Share this content:
Surgeon-Specific Learning Curve for Transoral Robotic Surgery
Surgeon-Specific Learning Curve for Transoral Robotic Surgery

MONDAY, Feb. 13, 2017 (HealthDay News) -- The learning curve for transoral robotic surgery (TORS) for squamous cell carcinoma of the oropharynx (OPSCC) is surgeon-specific, according to a study published online Feb. 9 in JAMA Otolaryngology-Head & Neck Surgery.

William G. Albergotti, M.D., from the University of Pittsburgh Medical Center, and colleagues examined learning curves for oncologic TORS surgeons in a retrospective review of patients undergoing TORS for OPSCC. A total of 382 transoral robotic procedures were identified, of which 160 met the inclusion criteria for three surgeons (68, 37, and 55 for surgeons A, B, and C, respectively).

The researchers found that the inflection points for the final margin status learning curves were 27 and 25 cases for surgeons A and C, respectively. For surgeon B, there was no inflection point for final margin status. For the mean time to resection, inflection points were 39, 30, and 27 cases, respectively, for surgeons A, B, and C.

"Using metrics of positive margin rate and time to resection of the main surgical specimen, the learning curve for TORS for OPSCC is surgeon-specific," the authors write. "Inflection points for most learning curves peak between 20 and 30 cases."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »